News >

PARP Inhibition Continues to Make Waves in Ovarian Cancer

Ellie Leick
Published: Monday, Aug 19, 2019

Terry L. Evans, MD

Terry L. Evans, MD

PARP inhibitors can be helpful therapeutic tools in prolonging the time between chemotherapy treatments in patients with ovarian cancer who are in their third line of therapy or beyond, explained Terry L. Evans, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Oncology Briefings™: A Nurses' Guide to Managing Adverse Events Associated with PARP InhibitorsJun 30, 20201.0
Publication Bottom Border
Border Publication